Dibrugarh, May 1 -- The ICMR-Regional Medical Research Centre, North East (ICMR-RMRC NE) in Assam's Dibrugarh on Wednesday announced the successful transfer of its indigenously developed CRISPR-Cas-based diagnostic technology for the ultra-sensitive and rapid detection of tuberculosis (TB)to Meril Diagnostics Pvt. Ltd for large-scale commercialization.

The formal technology transfer was cemented through a Memorandum of Agreement (MoA) signed by Subarna Roy, Director (Additional Charge) of ICMR-RMRC NE, and Meril Diagnostics Pvt. Ltd., a leading medical diagnostics company.

ICMR-RMRC NE, established in Dibrugarh on July 12th, 1982, serves the eight northeastern states, focusing on crucial biomedical research and strengthening healthcare ...